SMS Pharmaceuticals Limited

NSE SMSPHARMA.NS

SMS Pharmaceuticals Limited Free Cash Flow Per Share for the year ending March 31, 2024: USD -0.00

SMS Pharmaceuticals Limited Free Cash Flow Per Share is USD -0.00 for the year ending March 31, 2024, a 73.14% change year over year. Free cash flow per share is the free cash flow generated per share. Indicates investment potential based on cash flow generation.

SMS Pharmaceuticals Limited Free Cash Flow Per Share for the year ending March 31, 2023 was USD -0.01, a -153.15% change year over year.
SMS Pharmaceuticals Limited Free Cash Flow Per Share for the year ending March 31, 2022 was USD 0.02, a 120.43% change year over year.
SMS Pharmaceuticals Limited Free Cash Flow Per Share for the year ending March 31, 2021 was USD -0.10, a -1,987.40% change year over year.
SMS Pharmaceuticals Limited Free Cash Flow Per Share for the year ending March 31, 2020 was USD -0.00, a -118.68% change year over year.

Key data

Date	Free Cash Flow Per Share	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)

NSE: SMSPHARMA.NS

SMS Pharmaceuticals Limited

CEO	Mr. Ramesh Babu Potluri
IPO Date	Feb. 28, 2007
Location	India
Headquarters	Plot No. 72
Employees	1,197
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care Plastics

Description

SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, antiemetic, antiepileptic, antipsychotic, anti-hypertensive, anti-anginal, anti-viral, urinary antispasmodic, and anti-retroviral APIs. It is also involved in the contract research activities. The company also exports its products. SMS Pharmaceuticals Limited was incorporated in 1987 and is based in Hyderabad, India.

Key trends

Past 5 years